Abstract
The fluorescence microscope is a standard tool in any cell biology lab, enabling the visualisation of appropriately labelled probe molecules in the context of cell anatomy. These probe molecules can be used to image various aspects of cell physiology and biochemistry, for example, the levels of intracellular Ca2+, the location, binding and mobility of specific proteins and, using gene reporter constructs, the transcriptional activity of specific genes. The techniques of molecular imaging allow similar measurements to be made deep inside the tissues of a living organism, for example in tumours in mouse models of cancer. Since many of the molecular imaging modalities that are employed in the laboratory can also be used clinically, the techniques of molecular imaging, in principle, also permit investigation of these fundamental aspects of tumour biology in the clinic. These techniques are set to play a key role in translational research, that is in translating our growing understanding of the cell biology of cancer and pre-invasive disease into new ways of detecting and treating the disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Eisenhauer E, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
Weissleder R (1999) Molecular imaging: exploring the next frontier. Radiology 212:609–614
Weissleder R, Mahmood U (2001) Molecular imaging. Radiology 219:316–333
Weissleder R, Pittet M (2008) Imaging in the era of molecular oncology. Nature 452:580–589
Gambhir SS (2002) Molecular imaging of cancer with positron emisson tomography. Nat Rev Cancer 2:683–693
Margolis D, Hoffman J, Herfkens R, Jeffrey R, Quon A, Gambhir S (2007) Molecular imaging techniques in body imaging. Radiology 245:333–356
Sullivan D, Kelloff G (2005) Seeing into cells – The promise of in vivo molecular imaging in oncology. EMBO Rep 6:292–296
Weber W (2005) Use of PET for monitoring cancer therapy and for predicting outcome. J Nucl Med 46:983–995
Czernin J, Weber WA, Herschman HR (2006) Molecular imaging in the development of cancer therapeutics. Annu Rev Med 57:99–118
Weber WA (2006) Positron emission tomography as an imaging biomarker. J Clin Oncol 24:3282–3292
Neves AA, Brindle KM (2006) Assessing responses to cancer therapy using molecular imaging. Biochim Biophys Acta 1766:242–261
Brindle K (2008) New approaches for imaging tumour responses to treatment. Nat Rev Cancer 8:1–14
Juweid M, Cheson B (2006) Positron-emission tomography and assessment of cancer therapy. N Engl J Med 354:496–507
Weissleder R (2001) Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2:1–8
Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7:654–658
Testoni PA, Mangiavillano B (2008) Optical coherence tomography in detection of dysplasia and cancer of the gastrointestinal tract and bilio-pancreatic ductal system. World J Gastroenterol 14:6444–6452
Kara MA, Bergman JJ (2006) Autofluorescence imaging and narrow-band imaging for the detection of early neoplasia in patients with Barrett’s esophagus. Endoscopy 38:627–631
Moghissi K, Dixon K, Stringer MR (2008) Current indications and future perspective of fluorescence bronchoscopy: a review study. Photodiagnosis Photodyn Ther 5:238–246
Hsiung PL, Hardy J, Friedland S et al (2008) Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. Nat Med 14:454–458
Kurhanewicz J, Swanson MG, Nelson SJ, Vigneron DB (2002) Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging 16:451–463
Sawyers C (2008) The cancer biomarker problem. Nature 452:548–552
Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571–579
Jana S, Blaufox MD (2006) Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 36:51–72
Lauterbur PC (1973) Image formation by induced local interactions: examples employing nuclear magnetic resonance. Nature 242:190–191
Hoult D, Busby S, Gadian D, Radda G, Richards R, Seeley P (1974) Observation of tissue metabolites using 31P nuclear magnetic resonance. Nature 252:285–287
Gadian DG, Radda GK (1981) NMR studies of tissue metabolism. Ann Rev Biochem 50:69–83
Negendank W (1992) Studies of human tumours by MRS: a review. NMR Biomed 5:303–324
Glunde K, Jacobs MA, Bhujwalla ZM (2006) Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 6:821–829
Gadian DG (1995) NMR and its applications to living systems, 2nd edn. Oxford University Press, Oxford
McRobbie DW, Moore EA, Graves MJ, Prince MR (2006) MRI from picture to proton, 2nd edn. Cambridge University Press, Cambridge
Wuthrich K (1986) NMR of Proteins and Nucleic Acids. Wiley-Interscience, New York
Lindon JC, Nicholson JK, Wilson ID (1996) Direct coupling of chromatographic separations to NMR spectroscopy. Prog Nucl Magn Reson Spectrosc 29:1–49
Raichle ME (2001) Bold insights. Nature 412:128–130
Logothetis NK (2008) What we can do and what we cannot do with fMRI. Nature 453:869–878
Robinson SP, Howe FA, Griffiths JR (1995) Noninvasive monitoring of carbogen-induced changes in tumor blood-flow and oxygenation by functional magnetic-resonance-imaging. Int J Radiat Oncol Biol Phys 33:855–859
van Zijl PCM, Moonen CTW, Faustino P, Pekar J, Kaplan O, Cohen JS (1991) Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. Proc Natl Acad Sci USA 88:3228–3232
Zhao M, Pipe JG, Bonnett J, Evelhoch JL (1996) Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 73:61–64
Chenevert TL, Stegman LD, Taylor JMG et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92:2029–2036
Moffat BA, Chenevert TL, Lawrence TS et al (2005) Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102:5524–5529
Aime S, Cabella C, Colombatto S, GeninattiCrich S, Gianollio E, Maggioni F (2002) Insights into the use of paramagnetic Gd(III) complexes in MR-molecular imaging investigations. J Magn Reson Imaging 16:394–406
Bulte JWM, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484–499
Stuber M, Gilson WD, Schar M et al (2007) Positive contrast visualization of iron oxide-labeled stem cells using inversion-recovery with ON-Resonant water suppression (IRON). Magn Reson Med 58:1072–1077
Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM (2007) Molecular imaging and therapy of atherosclerosis with targeted nanoparticles. J Magn Reson Imaging 25:667–680
Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP (2004) MRI detection of single particles for cellular imaging. Proc Natl Acad Sci USA 101:10901–10906
de Vries I, Lesterhuis W, Barentsz J et al (2005) Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 23:1407–1413
Leach MO, Brindle KM, Evelhoch JL et al (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92:1599–1610
Brasch R, Pham C, Shames D et al (1997) Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 7:68–74
Barrett T, Kobayashi H, Brechbiel M, Choyke PL (2006) Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol 60:353–366
McDonald DM, Choyke PL (2003) Imaging of angiogenesis: from microscope to clinic. Nat Med 9:713–725
Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24:3293–3298
Tozer GM, Kanthou C, Baguley BC (2005) Disrupting tumour blood vessels. Nat Rev Cancer 5:423–435
Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172–187
Morgan B, Thomas AL, Drevs J et al (2003) Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21:3955–3964
Stevenson JP, Rosen M, Sun WJ et al (2003) Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow. J Clin Oncol 21:4428–4438
Aime S, Castelli D, Terreno E (2002) Novel pH-reporter MRI contrast agents. Angew Chem Int Ed 41:4334–4336
Gillies RJ, Raghunand N, Garcia-Martin ML, Gatenby RA (2004) pH imaging. A review of pH measurement methods and applications in cancers. IEEE Eng Med Biol Mag 23:57–64
Aime S, Fedeli F, Sanino A, Terreno E (2006) A R-2/R-1 ratiometric procedure for a concentration-independent, pH-responsive, Gd(III)-based MRI agent. J Am Chem Soc 128: 11326–11327
Aime S, Barge A, Castelli DD et al (2002) Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 47:639–648
Artemov D, Mori N, Ravi R, Bhujwalla ZM (2003) Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 63:2723–2727
Artemov D, Mori N, Okollie B, Bhujwalla ZM (2003) MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 49:403–408
Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KCP (1998) Detection of tumour angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging. Nat Med 4:623–626
Winter PM, Caruthers SD, Kassner A et al (2003) Molecular Imaging of angiogenesis in nascent vx-2 rabbit tumors using a novel alpha(v)beta(3)-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 63:5838–5843
Zhao M, Beauregard DA, Loizou L, Davletov B, Brindle KM (2001) Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7:1241–1244
van Tilborg GAF, Mulder WJM, Deckers N et al (2006) Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem 17:741–749
Krishnan AS, Neves AA, de Backer MM et al (2008) Detection of cell death in tumors using MRI and a gadolinium-based targeted contrast agent. Radiology 246:854–862
Lauenstein T, Salman K, Morreira R et al (2007) Nephrogenic systemic fibrosis: center case review. J Magn Reson Imaging 26:1198–1203
Podo F, Sardanelli F, Iorio E et al (2007) Abnormal choline phospholipid metabolism in breast and ovary cancer: molecular bases for noninvasive imaging approaches. Curr Med Imaging Rev 3:123–137
Hu JN, Feng WZ, Hua J et al (2009) A high spatial resolution in vivo 1H magnetic resonance spectroscopic imaging technique for the human breast at 3 T. Med Phys 36:4870–4877
Kurhanewicz J, Vigneron DB, Nelson SJ (2000) Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia 2:166–189
Meisamy S, Bolan PJ, Baker EH et al (2004) Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo H-1 MR spectroscopy - A pilot study. Radiology 233:424–431
Kumar R, Kumar M, Jagannathan NR, Gupta NP, Hemal AK (2004) Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate. Urol Res 32:36–40
Mueller-Lisse UG, Scherr MK (2007) Proton MR spectroscopy of the prostate. Eur J Radiol 63:351–360
Futterer JJ, Heijmink S, Scheenen TWJ et al (2006) Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241:449–458
Magalhaes A, Godfrey W, Shen YM, Hu JN, Smith W (2005) Proton magnetic resonance spectroscopy of brain tumors correlated with pathology. Acad Radiol 12:51–57
Chen J, Huang SL, Li T, Chen XL (2006) In vivo research in astrocytoma cell proliferation with H-1-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry. Neuroradiology 48:312–318
Spampinato MV, Smith JK, Kwock L et al (2007) Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol 188:204–212
Chernov MF, Nakaya K, Kasuya H et al (2009) Metabolic alterations in the peritumoral brain in cases of meningiomas: H-1-MRS study. J Neurol Sci 284:168–174
Hazany S, Hesselink JR, Healy JF, Imbesi SG (2007) Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas. Neuroradiology 49:121–127
Tate A, Underwood J, Acosta D et al (2006) Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra. NMR Biomed 19:411–434
Roden M, Shulman GI (1999) Applications of NMR spectroscopy to study muscle glycogen metabolism in man. Annu Rev Med 50:277–290
Ardenkjaer-Larsen JH, Fridlund B, Gram A et al (2003) Increase in signal-to-noise ratio of >10, 000 times in liquid-state NMR. Proc Natl Acad Sci USA 100:10158–10163
Gallagher F, Kettunen M, Brindle K (2009) Biomedical applications of hyperpolarized 13C magnetic resonance imaging. Prog NMR Spec 55:285–295
Golman K, Petersson JS, Magnusson P et al (2008) Cardiac metabolism measured noninvasively by hyperpolarized 13C MRI. Magn Reson Med 59:1005–1013
Day SE, Kettunen MI, Gallagher FA et al (2007) Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nat Med 13:1382–1387
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899
Albers M, Bok R, Chen A et al (2008) Hyperpolarized C-13 lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res 68:8607–8615
Gallagher FA, Kettunen MI, Hu DE et al (2009) Production of hyperpolarized [1, 4-C-13(2)]malate from [1, 4-C-13(2)]fumarate is a marker of cell necrosis and treatment response in tumors. Proc Natl Acad Sci USA 106:19801–19806
Gallagher F, Kettunen M, Day S, Lerche M, Brindle K (2008) 13C Magnetic resonance spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine. Magn Reson Med 60:253–257
Gallagher F, Kettunen M, Day S et al (2008) Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labeled bicarbonate. Nature 453:940–943
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580
Robbins E (2008) Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer 51:453–457
Carney JP, Townsend DW, Rappoport V, Bendriem B (2006) Method for transforming CT images for attenuation correction in PET/CT imaging. Med Phys 33:976–983
Moses WW (2007) Recent advances and future advances in time-of-flight PET. Nucl Instrum Methods Phys Res A 580:919–924
Ullrich RT, Kracht L, Brunn A et al (2009) Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med 50:1962–1968
Soloviev D, Fini A, Chierichetti F, Al-Nahhas A, Rubello D (2008) PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective. Eur J Nucl Med Mol Imaging 35:942–949
Di Bartolo N, Sargeson AM, Smith SV (2006) New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr. Org Biomol Chem 4:3350–3357
Voss SD, Smith SV, DiBartolo N et al (2007) Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci USA 104:17489–17493
Emonds KM, Swinnen JV, Mortelmans L, Mottaghy FM (2009) Molecular imaging of prostate cancer. Methods 48:193–199
Beer AJ, Haubner R, Sarbia M et al (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12:3942–3949
Beer AJ, Lorenzen S, Metz S et al (2008) Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG. J Nucl Med 49:22–29
Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ (1996) Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res 2:933–939
Peterson LM, Mankoff DA, Lawton T et al (2008) Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol. J Nucl Med 49: 367–374
Mortimer JE, Dehdashti F, Siegel BA, Trinkaus K, Katzenellenbogen JA, Welch MJ (2001) Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol 19:2797–2803
Shah C, Miller TW, Wyatt SK et al (2009) Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer. Clin Cancer Res 15: 4712–4721
Cohen A, Shirvan A, Levin G, Grimberg H, Reshef A, Ziv I (2009) From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 19:625–637
Nguyen QD, Smith G, Glaser M, Perumal M, Arstad E, Aboagye EO (2009) Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Proc Natl Acad Sci USA 106:16375–16380
Eschmann SM, Paulsen F, Reimold M et al (2005) Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 46:253–260
Spence AM, Muzi M, Swanson KR et al (2008) Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival. Clin Cancer Res 14:2623–2630
Lee N, Nehmeh S, Schoder H et al (2009) Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 75:101–108
Lehmann S, Stiehl DP, Honer M et al (2009) Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events. Proc Natl Acad Sci USA 106:14004–14009
Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617–1626
Miyagawa T, Gogiberidze G, Serganova I et al (2008) Imaging of HSV-tk Reporter gene expression: comparison between [18F]FEAU, [18F]FFEAU, and other imaging probes. J Nucl Med 49:637–648
Kang KW, Min JJ, Chen X, Gambhir SS (2005) Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol Imaging Biol 7:296–303
Yaghoubi SS, Gambhir SS (2006) PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG. Nat Protoc 1:3069–3075
Deng WP, Wu CC, Lee CC et al (2006) Serial in vivo imaging of the lung metastases model and gene therapy using HSV1-tk and ganciclovir. J Nucl Med 47:877–884
Maatta AM, Samaranayake H, Pikkarainen J, Wirth T, Yla-Herttuala S (2009) Adenovirus mediated herpes simplex virus-thymidine kinase/ganciclovir gene therapy for resectable malignant glioma. Curr Gene Ther 9:356–367
Gambhir SS, Bauer E, Black ME et al (2000) A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97:2785–2790
Dingli D, Kemp BJ, O’Connor MK, Morris JC, Russell SJ, Lowe VJ (2006) Combined I-124 positron emission tomography/computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 8:16–23
Che J, Doubrovin M, Serganova I, Ageyeva L, Zanzonico P, Blasberg R (2005) hNIS-IRES-eGFP dual reporter gene imaging. Mol Imaging 4:128–136
Niu G, Gaut AW, Ponto LL et al (2004) Multimodality noninvasive imaging of gene transfer using the human sodium iodide symporter. J Nucl Med 45:445–449
Scholz IV, Cengic N, Baker CH et al (2005) Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer. Gene Ther 12:272–280
Park SY, Kwak W, Thapa N et al (2008) Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. J Nucl Med 49:1480–1488
Kim YJ, Dubey P, Ray P, Gambhir SS, Witte ON (2004) Multimodality imaging of lymphocytic migration using lentiviral-based transduction of a tri-fusion reporter gene. Mol Imaging Biol 6:331–340
Penuelas I, Haberkorn U, Yaghoubi S, Gambhir SS (2005) Gene therapy imaging in patients for oncological applications. Eur J Nucl Med Mol Imaging 32(Suppl 2):S384–S403
Dubey P, Su H, Adonai N et al (2003) Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proc Natl Acad Sci USA 100:1232–1237
Koehne G, Doubrovin M, Doubrovina E et al (2003) Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat Biotechnol 21:405–413
Doubrovin M, Ponomarev V, Beresten T et al (2001) Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc Natl Acad Sci USA 98:9300–9305
Serganova I, Doubrovin M, Vider J et al (2004) Molecular imaging of temporal dynamics and spatial heterogeneity of hypoxia-inducible factor-1 signal transduction activity in tumors in living mice. Cancer Res 64:6101–6108
Che J, Doubrovin M, Serganova I et al (2007) HSP70-inducible hNIS-IRES-eGFP reporter imaging: response to heat shock. Mol Imaging 6:404–416
Catana C, Procissi D, Wu Y et al (2008) Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci USA 105:3705–3710
Schlemmer HP, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028–1035
Hofmann M, Steinke F, Scheel V et al (2008) MRI-based attenuation correction for PET/MRI: a novel approach combining pattern recognition and atlas registration. J Nucl Med 49:1875–1883
Martinez-Moller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med 50:520–526
Beekman F, van der Have F (2007) The pinhole: gateway to ultra-high-resolution three-dimensional radionuclide imaging. Eur J Nucl Med Mol Imaging 34:151–161
Sosabowski JK, Mather SJ (2006) Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat Protoc 1:972–976
Tomura N, Watanabe O, Takahashi S et al (2006) Comparison of 201Tl-chloride SPECT with 99mtc-MIBI SPECT in the depiction of malignant head and neck tumors. Ann Nucl Med 20:107–114
Nishiyama Y, Yamamoto Y, Yokoe K et al (2004) Superimposed dual-isotope SPECT using 99mTc-hydroxymethylene diphosphonate and 201Tl-chloride to assess cartilage invasion in laryngohypopharyngeal cancer. Ann Nucl Med 18:527–532
Suzuki A, Togawa T, Kuyama J et al (2004) Evaluation of mandibular invasion by head and neck cancers using 99mTc-methylene diphosphonate or 99mTc-hydroxymethylene diphosphonate and 201Tl chloride dual isotope single photon emission computed tomography. Ann Nucl Med 18:399–408
van de Wiele C, Lahorte C, Vermeersch H et al (2003) Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. J Clin Oncol 21:3483–3487
Kartachova M, van Zandwijk N, Burgers S, van Tinteren H, Verheij M, Valdes Olmos RA (2007) Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. J Clin Oncol 25:2534–2539
Balon HR, Goldsmith SJ, Siegel BA et al (2001) Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med 42:1134–1138
Perri M, Erba P, Volterrani D et al (2008) Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging 52:323–333
Akgun A, Cok G, Karapolat I, Goksel T, Burak Z (2006) Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer. Ann Nucl Med 20:269–275
Saggiorato E, Angusti T, Rosas R et al (2009) 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med 50:1785–1793
Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567–1572
Troyan SL, Kianzad V, Gibbs-Strauss SL et al (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16:2943–2952
Winer JH, Choi HS, Gibbs-Strauss SL, Ashitate Y, Colson YL, Frangioni JV (2010) Intraoperative localization of insulinoma and normal pancreas using invisible near-infrared fluorescent light. Ann Surg Oncol 17:1094–1100
Rao J, Dragulescu-Andrasi A, Yao H (2007) Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 18:17–25
Lyons SK, Lim E, Clermont AO et al (2006) Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice. Cancer Res 66:4701–4707
Fan F, Wood KV (2007) Bioluminescent assays for high-throughput screening. Assay Drug Dev Technol 5:127–136
Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO (2005) Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 11:435–443
Loening AM, Wu AM, Gambhir SS (2007) Red-shifted Renilla reniformis luciferase variants for imaging in living subjects. Nat Meth 4:641–643
Loening AM, Dragulescu-Andrasi A, Gambhir SS (2010) A red-shifted Renilla luciferase for transient reporter-gene expression. Nat Meth 7:5–6
Rabinovich BA, Ye Y, Etto T et al (2008) Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer. Proc Natl Acad Sci U S A 105:14342–14346
Deroose CM, De A, Loening AM et al (2007) Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J Nucl Med 48:295–303
Kuo C, Coquoz O, Troy TL, Xu H, Rice BW (2007) Three-dimensional reconstruction of in vivo bioluminescent sources based on multispectral imaging. J Biomed Opt 12:024007
Jenkins DE, Yu SF, Hornig YS, Purchio T, Contag PR (2003) In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer. Clin Exp Metastasis 20:745–756
Edinger M, Cao YA, Verneris MR, Bachmann MH, Contag CH, Negrin RS (2003) Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood 101:640–648
Zhang C, Yan Z, Arango ME, Painter CL, Anderes K (2009) Advancing bioluminescence imaging technology for the evaluation of anticancer agents in the MDA-MB-435-HAL-Luc mammary fat pad and subrenal capsule tumor models. Clin Cancer Res 15:238–246
Vooijs M, Jonkers J, Lyons S, Berns A (2002) Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 62:1862–1867
Zhang N, Lyons S, Lim E, Lassota P (2009) A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging. Clin Cancer Res 15:4915–4924
Uhrbom L, Nerio E, Holland EC (2004) Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med 10:1257–1260
Hamstra DA, Bhojani MS, Griffin LB, Laxman B, Ross BD, Rehemtulla A (2006) Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res 66:7482–7489
Laxman B, Hall DE, Bhojani MS et al (2002) Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci USA 99:16551–16555
Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A (2007) Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res 13:1839–1846
Zhang L, Lee KC, Bhojani MS et al (2007) Molecular imaging of Akt kinase activity. Nat Med 13:1114–1119
Paulmurugan R, Gambhir SS (2003) Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation. Anal Chem 75: 1584–1589
Luker GD, Sharma V, Pica CM et al (2002) Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci USA 99:6961–6966
Luker KE, Gupta M, Luker GD (2009) Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 23:823–834
Chan CT, Paulmurugan R, Gheysens OS, Kim J, Chiosis G, Gambhir SS (2008) Molecular imaging of the efficacy of heat shock protein 90 inhibitors in living subjects. Cancer Res 68:216–226
Paulmurugan R, Gambhir SS (2006) An intramolecular folding sensor for imaging estrogen receptor-ligand interactions. Proc Natl Acad Sci USA 103:15883–15888
Inoue Y, Izawa K, Kiryu S, Tojo A, Ohtomo K (2008) Diet and abdominal autofluorescence detected by in vivo fluorescence imaging of living mice. Mol Imaging 7:21–27
Xu H, Rice BW (2009) In-vivo fluorescence imaging with a multivariate curve resolution spectral unmixing technique. J Biomed Opt 14:064011
Niedre MJ, de Kleine RH, Aikawa E, Kirsch DG, Weissleder R, Ntziachristos V (2008) Early photon tomography allows fluorescence detection of lung carcinomas and disease progression in mice in vivo. Proc Natl Acad Sci USA 105:19126–19131
Mayinger B, Neumann F, Kastner C, Haider T, Schwab D (2010) Hexaminolevulinate-induced fluorescence colonoscopy versus white light endoscopy for diagnosis of neoplastic lesions in the colon. Endoscopy 42:28–33
Kimura T, Muguruma N, Ito S et al (2007) Infrared fluorescence endoscopy for the diagnosis of superficial gastric tumors. Gastrointest Endosc 66:37–43
Upadhyay R, Sheth RA, Weissleder R, Mahmood U (2007) Quantitative real-time catheter-based fluorescence molecular imaging in mice. Radiology 245:523–531
Zhong W, Celli JP, Rizvi I et al (2009) In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer 101:2015–2022
Winkler F, Kozin SV, Tong RT et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6:553–563
Fukumura D, Jain RK (2008) Imaging angiogenesis and the microenvironment. APMIS 116:695–715
Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11:1287–1296
Kienast Y, von Baumgarten L, Fuhrmann M et al (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16:116–122
Helmchen F, Denk W (2005) Deep tissue two-photon microscopy. Nat Meth 2:932–940
Citrin D, Lee AK, Scott T et al (2004) In vivo tumor imaging in mice with near-infrared labeled endostatin. Mol Cancer Ther 3:481–488
Montet X, Figueiredo JL, Alencar H, Ntziachristos V, Mahmood U, Weissleder R (2007) Tomographic fluorescence imaging of tumor vascular volume in mice. Radiology 242:751–758
Ke S, Wen X, Gurfinkel M et al (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 63:7870–7875
Moore A, Medarova Z, Potthast A, Dai G (2004) In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 64:1821–1827
Wu Y, Cai W, Chen X (2006) Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. Mol Imaging Biol 8:226–236
Mulder WJ, Castermans K, van Beijnum JR et al (2009) Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 12:17–24
Koyama Y, Hama Y, Urano Y, Nguyen DM, Choyke PL, Kobayashi H (2007) Spectral fluorescence molecular imaging of lung metastases targeting HER2/neu. Clin Cancer Res 13:2936–2945
Edgington LE, Berger AB, Blum G et al (2009) Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat Med 15:967–973
Blum G, Mullins SR, Keren K et al (2005) Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat Chem Biol 1:203–209
Blum G, von Degenfeld G, Merchant MJ, Blau HM, Bogyo M (2007) Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat Chem Biol 3:668–677
Grimm J, Kirsch DG, Windsor SD et al (2005) Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci USA 102:14404–14409
McIntyre JO, Matrisian LM (2009) Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Meth Mol Biol 539:155–174
Ogawa M, Kosaka N, Choyke PL, Kobayashi H (2009) In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res 69:1268–1272
Urano Y, Asanuma D, Hama Y et al (2009) Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat Med 15:104–109
Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M (2003) A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113:151–160
Yang M, Li L, Jiang P, Moossa AR, Penman S, Hoffman RM (2003) Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA 100:14259–14262
Amoh Y, Katsuoka K, Hoffman RM (2008) Color-coded fluorescent protein imaging of angiogenesis: the AngioMouse models. Curr Pharm Des 14:3810–3819
Sakaue-Sawano A, Kurokawa H, Morimura T et al (2008) Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132:487–498
Mocanu JD, Moriyama EH, Chia MC et al (2004) Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapy. Mol Imaging 3:352–355
Kimball KJ, Rivera AA, Zinn KR et al (2009) Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer. Mol Imaging 8:264–277
Kesarwala AH, Prior JL, Sun J, Harpstrite SE, Sharma V, Piwnica-Worms D (2006) Second-generation triple reporter for bioluminescence, micro-positron emission tomography, and fluorescence imaging. Mol Imaging 5:465–474
Ray P, Tsien R, Gambhir SS (2007) Construction and validation of improved triple fusion reporter gene vectors for molecular imaging of living subjects. Cancer Res 67:3085–3093
Shu X, Royant A, Lin MZ et al (2009) Mammalian expression of infrared fluorescent proteins engineered from a bacterial phytochrome. Science 324:804–807
Vakoc BJ, Lanning RM, Tyrrell JA et al (2009) Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med 15: 1219–1223
De la Zerda A, Zavaleta C, Keren S et al (2008) Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 3:557–562
Razansky D, Baeten J, Ntziachristos V (2009) Sensitivity of molecular target detection by multispectral optoacoustic tomography (MSOT). Med Phys 36:939–945
Kim JW, Galanzha EI, Shashkov EV, Moon HM, Zharov VP (2009) Golden carbon nanotubes as multimodal photoacoustic and photothermal high-contrast molecular agents. Nat Nanotechnol 4:688–694
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Lyons, S.K., Brindle, K.M. (2011). Molecular Imaging of Cancer and the Implications for Pre-invasive Disease. In: Fitzgerald, R. (eds) Pre-Invasive Disease: Pathogenesis and Clinical Management. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6694-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6694-0_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6693-3
Online ISBN: 978-1-4419-6694-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)